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FOREWORD

A ROT IN HEAVEN
A POWERFUL INVESTIGATIVE PARTNERSHIP,
THE OPIOID CRISIS, PILL PROFITS, AND A
PULITZER PRIZE
Becky L. Jacobs*
“Almost Heaven, West Virginia”
Bill Danoff, Taffy Nivert, and John Denver1
“All the host of heaven shall rot away, and the skies roll up like a
scroll.”
Isaiah 34:42

_________________________________
In the spring of 2018, when the Tennessee Journal
of Law and Policy hosted the “Healing Appalachia: The
Role of Professionals in Solving the Opioid Crisis”
symposium, there were more than 400 lawsuits pending
against corporations that manufacture, distribute, and
retail opioids in just one consolidated case in the federal
Waller Lansden Distinguished Professor of Law, The
University of Tennessee College of Law. Email:
jacobs@utk.edu.
1 Bill Danoff, Taffy Nivert & John Denver, Take Me Home,
Country Roads (April 12, 1971).
2 Isaiah 34:4 (English Standard Version).
*
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district court for the Northern District of Ohio.3 This
single, consolidated case initially involved only claims
brought by governmental entities, but the Judicial Panel
on Multidistrict Litigation consolidating the cases
acknowledged that the action potentially could include
claims brought by individuals, consumers, hospitals, and
third party payors, as well as additional categories of
defendants.4
It is not hyperbole to say that we can thank Eric
Eyre of the Charleston Gazette-Mail, of Charleston, West
Virginia, for these lawsuits and for the momentum that
we now are experiencing in support of a response to the
national opioid crisis. The government, the legal
community, and many media outlets seemingly were
willing to ignore the opiate plague that was infecting our
communities, but Eric’s Pulitzer Prize-winning series of
articles5 made it impossible for anyone to profess
ignorance any longer.
As lawyers, we also should take pride in the role
that our colleagues from WVU College of Law, Pat
McGinley and Suzanne Weise, played in supporting
Eric’s efforts to uncover the shocking data that appeared
In re Nat’l Prescription Opiate Litig., MDL No. 1:17-MD-2804
(N.D. Ohio 2017) [hereinafter “MDL Litigation”]; see also Jan
Hoffman, Can This Judge Solve the Opioid Crisis?, N.Y. TIMES
(Mar. 7, 2018), https://www.nytimes.com/2018/03/05/health/
opioid-crisis-judge-lawsuits.html [https://perma.cc/H87X-UYN
W].
4 Transfer Order, In re Nat’l Prescription Opiate Litig., MDL
No. 1:17-MD-2804 (N.D. Ohio Dec. 12, 2017).
5 Eric also won the Scripps Howard First Amendment Award,
was a finalist for the Selden Ring awards, and won a first-place
award for investigative reporting from the Association for
Healthcare Journalists. See Susan Heavey, Reporter’s Work
Pushes Regulators, Legislators to Act on Opioids, ASS’N HEALTH
CARE JOURNALISTS: COVERING HEALTH (May 8, 2017),
https://healthjournalism.org/blog/2017/05/reporters-workpushes-regulators-legislators-to-act-on-opioids/ [https://perma.
cc/MDV6-FF6W].
3
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in his articles. Without their tireless efforts, Eric may not
have been able to prevail against the well-financed
political and industry resistance to accessing the data
that so starkly revealed the appalling opiate prescription
and distribution patterns in West Virginia.
To put the importance of Eric’s contribution, and
that of Pat and Suzanne, in perspective, consider the
odds against which they were fighting - and it is critical
to remember that, at the time Eric, Pat, and Suzanne
were seeking the distribution data, the only litigation
pending against any entity or individual involved in the
opioid distribution chain was the groundbreaking lawsuit
filed by then-West Virginia Attorney General Darrell
McGraw in 2012 against Cardinal Health.6 Eric’s
newspaper, the Gazette-Mail, was a family-owned, daily
newspaper with a print circulation of 37,000, and Pat and
Suzanne were providing their services pro bono.
Thus, the odds were enormous, considering the
Goliath-like financial resources of their opposition.
Opioid painkillers are a nearly $9 billion-a-year market
in the U.S. alone,7 and pharmaceutical companies such
as Purdue Pharma L.P., Johnson & Johnson, Teva,
Allergan PLC, and the Endo Health Solutions unit of
Endo International PLC have all earned billions over the
years from the sale of these drugs.8 Wholesale
distributors like McKesson Corp., Cardinal Health, and
AmerisourceBergen also have profited,9 as have the
See Records: Company Shipped Millions of Pills to West
Virginia, ASSOCIATED PRESS (Oct. 09, 2016), https://
www.apnews.com/20ed75eba921466aba2155f4a846dc75
[https://perm a.cc/P624-LN5W].
7 Haley Sweetland Edwards, The Drug Cascade, TIME (June 22,
2017), http://time.com/4828108/the-drug-cascade/ [https://per
ma.cc/Q9L5-A84S].
8 Stock Review: Two-Bagger Collegium Pharmaceutical Surges
108%, GLOBAL ROUND UP - STOCKS, Mar. 23, 2018.
9 Katie Tabeling, County Files Lawsuit Against Opioid
Manufacturers, CECIL WHIG (Elkton, Md.) (Jan. 9, 2018),
http://www.cecildaily.com/spotlight/county-files-lawsuit6
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physicians, pain clinics, and pharmacies prescribing and
dispensing these medications - some legitimately, some
not.10
These profits, though, have had a very high public
health cost, as Eric’s articles helped to expose. Here is
just a snapshot of the scale of what is being called an
epidemic11 and what President Trump declared, in
August of 2017, to be a “national emergency.”12 According
against-opioid-manufacturers/article_9be21338-13aa-5855b8be-caf98167bf5f.html
[https://perma.cc/Y2PV-RXFU]
(“Among the lawsuit’s 20 manu-facturing defendants, 14 are
subsidiaries of six pharmaceutical giants, including Endo,
Purdue, Johnson & Johnson, Teva, Allegran [sic] and
Mallinckrodt Pharmaceuticals. The remaining defendants are
McKesson, Cardinal Health and AmerisourceBergen characterized in the complaint as ‘the big three’ drug wholesale
distributors.”); see also Joey Garrison, Nashville Sues Opioid
Makers, THE TENNESSEAN, Dec. 23, 2017, at A5,
https://www.tennessean. com/story/news/2017/12/23/nashvillesues-opioid-manufacturers-recoup-costs-fighting-epidemic/
978861001/ [https://perma.cc/3CYT-3L8N] (“Cities like
Nashville and their taxpayers have borne the cost of the opioid
epidemic for far too long while the pharmaceutical
manufacturing industry, consisting of manufacturers and
distributors, has reaped astronomical profits[.]”).
10 Chris McGreal, ‘It was a Conspiracy’: Recovering Addicts
Wage Legal Battle over Prescription Use, GUARDIAN (UK) (Aug.
28, 2016), https://www.theguardian.com/us-news/2016/aug/
28/opioid-addiction-west-virginia-lawsuit [https://perma.cc/Z2
QP-HCJU] (“29 survivors of opioid addiction or relatives of
those who overdosed on painkillers . . . accuse doctors,
pharmacies and distributors in a rural corner of West Virginia
of pushing the powerful and highly addictive drugs, which have
properties similar to heroin.”).
11 U.S. DRUG ENF’T AGENCY, 2015 NATIONAL DRUG THREAT
ASSESSMENT SUMMARY, at iii (2015), https://www.dea.gov/
docs/2015%20NDTA%20Report.pdf [https://perma.cc/5USMJQJS].
12 Joel Achenbach, John Wagner & Lenny Bernstein, Trump
Says Opioid Crisis is a National Emergency, Pledges More
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to the CDC, more than 200,000 people in the U.S. died
from overdoses related to prescription opioids from 1999
to 2016.13 In 2016 alone, more than 46 people died every
day from overdoses involving prescription opioids.14 Also,
in 2016, three of the six states with the highest rates of
death due to drug overdose were located in close
geographic proximity to Tennessee: West Virginia (52.0
per 100,000), Ohio (39.1 per 100,000), and Kentucky (33.5
per 100,000).15 Tennessee’s rate was 24.5.16
These death rates are startling, but perhaps not
as surprising as one might first imagine given that
doctors prescribed enough opioids in 2016 to provide
every man, woman, and child in the U.S. with 36 pills
each.17 The highest prescribing rates, however,
reportedly were concentrated in the more rural states
that year, primarily in the South; in Tennessee, with the
second highest prescribing rate in the nation, every
resident could have had 70 pills each in 2016.18
The West Virginia numbers were even more
alarming. Eric’s research revealed that, “[i]n six years,
Money and Attention, WASH. POST (Aug. 10, 2017),
https://www.washingtonpost.com/politics/trump-declaresopioid-crisis-is-a-national-emergency-pledges-more-moneyand-attention/2017/08/10/5aaaae32-7dfe-11e7-83c7-5bd5460f0
d7e_story.html [https://perma.cc/GTU6-EMRN].
13 CTRS. FOR DISEASE CONTROL & PREVENTION, PRESCRIPTION
OPIOID OVERDOSE DATA, https://www.cdc.gov/drugoverdose/
data/overdose.html [https://perma.cc/6HVX-YYKV].
14 Id.
15 CTRS. FOR DISEASE CONTROL & PREVENTION, Rates, DRUG
OVERDOSE DEATH DATA, https://www.cdc.gov/drugoverdose/
data/statedeaths.html [https://perma.cc/Y7SX-YVZK].
16 Id.
17
PACIRA PHARM., INC., UNITED STATES FOR NONDEPENDENCE: AN ANALYSIS OF THE IMPACT OF OPIOID
OVERPRESCRIBING IN AMERICA 11 (2017), https://www.
pacira.com/sites/default/files/inline-files/USND_Stats_FINAL.
pdf [https://perma.cc/JAS3-WDWP].
18 Id. at Slides 11-12.
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drug wholesalers showered the state with 780 million
hydrocodone and oxycodone pills, while 1,728 West
Virginians fatally overdosed on those two painkillers[.]”19
Proportionately, in terms of geographical distribution
and in terms of population, that “amount[s] to 433 pain
pills for every man, woman and child in West Virginia.”20
In that state, the data that Eric secured uncovered a
dismaying pattern of distribution: small, independent
pharmacies received a disproportionate percentage of the
shipments of prescription opioids, e.g., wholesale
distributors delivered 1.4 million to 4.7 million
hydrocodone pills each year to locally-owned pharmacies
in Mingo and Logan counties when one of the busiest
Wal-Mart’s in West Virginia received only about 5,000
oxycodone and 9,500 hydrocodone pills annually.21
The companies involved in the opioid distribution
chain fought tooth-and-nail to keep these data from being
released, relying upon an impressive array of legal talent
to defend them on this issue22 and on the other claims of,
inter alia, negligence, public nuisance, violations of West
Virginia’s consumer act, etc. that arose in that ground-

Eric Eyre, Drug Firms Poured 780M Painkillers into WV
amid Rise of Overdoses, W.V. GAZETTE-MAIL (Dec. 16, 2016),
https://www.wv gazettemail.com/news/cops_and_courts/drugfirms-poured-m-painkillers-into-wv-amid-rise-of/article_99026
dad-8ed5-5075-90fa-adb906a36214.html [https://perma.cc/R38
M-FFSP].
20 Id.
21 Id.
22 AmerisourceBergen Drug Corp.’s Objection to Hearing Date
and Opposition to Motion on Behalf of the Charleston Gazette
to Intervene for the Limited Purpose of Moving the Circuit
Court to Unseal the Plaintiff’s Second Amended Complaint at
5, State ex rel. Morrissey v. AmerisourceBergen Drug Corp.,
Civil Action No. 12-C-141 (W. Va. Cir. Ct. 2016) (“And if [the
DEA] protect[s] any of that information from the intrusive
journalistic nose of the Gazette, then its confidential nature
must be respected.”).
19
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breaking case filed against them in West Virginia.23
Highly regarded national and West Virginia firms such
as Jones Day; Morgan Lewis; Steptoe & Johnson;
Jackson Kelly; Bowles Rice; and Spilman Thomas &
Battle were involved as defense counsel in the West
Virginia litigation.24
Pat, Suzanne, and Boone County, West Virginia
lawyer Tim Conaway provided essential, legal support to
the Gazette-Mail to force disclosure of the court records
that revealed these staggering distribution figures.25 The
sealed complaint in the State’s lawsuit contained
shipment data supplied by defendants and the U.S. DEA
during discovery in the case, and the West Virginia
Attorney General at that time, Patrick Morrisey,26 and
Complaint, State ex rel. McGraw v. AmerisourceBergen Drug
Corp., Civil Action No. 12-C-141, 2012 WL 2544646 (W. Va. Cir.
Ct. 2012).
24 See, e.g., Docket, West Virginia v. AmerisourceBergen, Civil
Action No. 2:12-CV-03760 (Closed Mar. 27, 2013).
25 See supra note 22. A conversation about these events
between Pat and Eric took place at an event at Washington &
Lee at https://livestream.com/wlu/wv-opioid/videos/165654080.
26 It is not without irony that Morrisey, who is running for the
U.S. Senate as an anti-opioid warrior, see Ken Blackwell, A
Clear Choice in WV Senate Battle: Conservative Patrick
Morrisey,
TOWNHALL:
OPINION
(July
14,
2017),
https://townhall.com/columnists/kenblackwell/ 2017/07/14/aclear-choice-in-wv-senate-battle-conservative-patrickmorrisey-n2354783 [https://perma.cc/9LD5-JD55], lobbied for
the Healthcare Distribution Management Association, a group
that represents drug wholesalers, in Washington, D.C. before
taking office as West Virginia Attorney General in 2013;
Cardinal Health is a member of this group. Louis Jacobson, A
Closer Look at Patrick Morrisey’s Family Ties to ‘Big Pharma’,
POLITIFACT (Mar. 27, 2018), http://www.politifact.com/truth-ometer/article/2018/mar/27/closer-look-patrick-morriseysfamily-ties-big-phar/ [https: //perma.cc/S59G-3MBS]. His wife,
Denise Henry Morrisey, is a partner with a Washington
lobbying firm retained by a number of major pharmaceutical
23
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other plaintiffs apparently agreed with the defendants’
arguments that the data were proprietary.27 Pat et al.
filed a motion on behalf of the Gazette-Mail to unseal the
complaint, and, despite a vigorous and lengthy fight to
maintain the confidentiality of the records, the judge
ordered the first ever public release of these previouslyundisclosed data.28
The import of this legal event cannot be
overstated - these data shifted the public discourse on the
opioid crisis. Opioid abuse was of course on the public
radar, but opinion did not appear to have moved much
beyond the “blame the addict” and “those damn pill mills”
mentality. The data in the lawsuit, however, told stories
of predatory practices and suffering people in pain, and
they inspired a sense of outrage and urgency that
prompted enforcement and reform efforts by regulators
and legislators.29
In West Virginia alone, for example, Cardinal
Health and AmerisourceBergen, two of the nation’s “big
three” drug wholesalers, agreed to pay the State a
combined $36 million to settle their lawsuits, and at least
one county commission has filed suit against all of the
“big three” to recover costs associated with prescription
drug abuse, with other West Virginia counties and cities
declaring their intentions to follow suit.30 Beyond West
clients, including several involved in the opioid industry, such
as Allergan, Johnson & Johnson, Janssen, Purdue Pharma,
and the membership of the Healthcare Leadership Council;
e.g., Cardinal, Sanofi, Johnson & Johnson, and Pfizer. Id.
27 Eric Eyre, Drug Firms Fueled ‘Pill Mills’ in Rural WV, W.V.
GAZETTE-MAIL (May 23, 2016), https://www.wvgazette
mail.com/news/cops_and_courts/drug-firms-fueled-pill-millsin-rural-wv/article_14c8e1a5-19b1-579d-9ed5-770f09589a22.
html [https://perma.cc/2B SG-3TFD].
28 See id.
29 See Heavey, supra note 5.
30 Eric Eyre, 2 Drug Distributors to Pay $36M to Settle WV
Painkiller Lawsuits, W.V. GAZETTE-MAIL (Jan. 9, 2017),
https://www.wvgazettemail.com/news/health/drug-
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Virginia’s borders, nearly every state Attorney General
has either filed a lawsuit against an opioid manufacturer
or distributor or is involved in an investigation and has
issued subpoenas for records.31 The MDL litigation
consolidated in the Northern District of Ohio currently
involves 400 cases filed by cities, counties, and states
against manufacturers and distributors of opiates, but
those involved have publicly acknowledged the
possibility that individuals, consumers, hospitals, and
third party payors might be added as plaintiffs.32 The
distributors-to-pay-m-to-settle-wv-painkiller-lawsuits/article_
b43534bd-b020-5f56-b9f3-f74270a54c07.html [https://perma.
cc/AVK9-TB9E].
31 Jerry Mitchell, Judge: Stop the Legal Fights and Curb the
Opioid Epidemic, CLARION LEDGER (Jan. 26, 2018),
https://www.clarion ledger.com/story/news/2018/01/26/opioidepidemic-litigation-dan-polster/1014046001/ [https://perma.cc/
C7J6-82E9]. Tennessee Attorney General Herbert H. Slatery,
III, for example, filed a 270-page complaint in the Knox County
Circuit Court in May of 2018 alleging that Purdue Pharma,
L.P. violated the Tennessee Consumer Protection Act vis-à-vis
false, deceptive, and/or unsubstantiated claims about its opioid
products or opioids in general including OxyContin; that it
breached a 2007 Agreed Final Judgment with the State
involving the cessation of sales promotions to prescribers
whose practices showed indications of abuse or diversion; and
that it created a public nuisance in Tennessee by significantly
interfering with the commercial marketplace and endangered
the life and health of the State's residents. See Tennessee’s
Motion, Memorandum in Support, and Order Granting Leave
to File Complaint under Seal, State ex rel. Slatery v. Purdue
Pharma, L.P., No. 1-173-18 (Tenn. Knox Co. Cir. Ct. 2018),
https://www.tn.gov/content/dam/tn/attorneygeneral/documents/
foi/purdue/purdue-motion-5-15-2018.pdf
[https://perma.cc/
S8E2-QDQC].
32 See supra note 4. The Tennessee Attorney General was not,
at the time of the publication of this Foreword, a party to the
federal multidistrict litigation pending in Cleveland, Ohio, but
that Office has publicly stated that it is “voluntarily engaging
in settlement discussions” in connection therewith. See Press
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lawsuits involve claims as widely divergent as public
nuisance, negligence, negligent misrepresentation,
fraud, and unjust enrichment as well as violations of
consumer protection laws and the state versions of the
Controlled Substances Act and RICO statute(s).33
The pool of defendants is also expanding. For
example, attributing blame and seeking recovery even
further afield, several cities in West Virginia brought a
class action suit against the Joint Commission on
Accreditation of Health Care Organizations on behalf of
all U.S. cities and towns.34 The Joint Commission is the
entity that certifies U.S. health care organizations and
programs. The suit alleges that the Joint Commission’s
Pain Management Standards “grossly misrepresented
the addictive qualities of opioids and fostered dangerous
pain control practices[.]”35
Outside of the civil context, prosecutors have
begun to bring charges against individuals for crimes
involving opioid abuse and distribution. In 2015, the
Obama-era U.S. Department of Justice issued a memo
directing federal prosecutors to pursue charges against
individual defendants.36 As an example of its use of this
policy, the DOJ charged John Kapoor, former CEO of
Insys Therapeutics, with conspiracy to commit
racketeering and mail and wire fraud in connection with
a bribe and kickback scheme associated with Subsys, the
Release No. 18-10, Tenn. Attorney Gen., No. 18-10: Tennessee
Attorney General Sues Purdue Pharma (May 15, 2018),
https://www.tn.gov/attorneygeneral/news/2018/5/15/pr1810.html [https://perma.cc/R459-5ZP4].
33 Id.
34 Complaint, City of Charleston v. The Joint Commission, No.
2:17-cv-04267 (S.D.W.V. Nov. 2, 2017).
35 Id. at 2.
36 Memorandum from Deputy Att’y Gen. Sally Q. Yates on
Individual Accountability for Corporate Wrongdoing (Sept. 9,
2015), https://www.justice.gov/archives/dag/file/769036/download
[https://perma.cc/8ARN-NPCS].
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company’s powerful synthetic opioid fentanyl in spray
form.37 Closer to home, in early 2017, a Maryville doctor
received a 10-year federal prison sentence for serving as
the supervising and prescribing doctor at a notorious
Maryville pain clinic.38
Legislative activity is also taking place in
response to the momentum generated in the wake of
Eric’s articles. That activity, however, is focused
primarily at the state level. As of April 2018, twentyeight states had enacted legislation that either limited,
offered guidance, or listed requirements related to opioid
prescribing practices.39 Further, every state except
Missouri has enacted monitoring program legislation
“designed to reduce doctor shopping and identify patients
at risk for substance use disorders.”40 In addition to these

Cynthia McFaddin, Billionaire Charged with Bribing
Doctors to Prescribe Opioids, NBC NEWS: HEALTH (Oct. 26,
2017),
https://www.nbcnews.com/storyline/americas-heroinepidemic/billionaire-charged-bribing-doctors-prescribeopioids-n814686
[https://perma.cc/W3D3-L62U]
(“The
corporation is not facing criminal charges and is still selling
Subsys - some $240 million worth of Subsys just last year.”).
38 Jamie Satterfield, Doctor for Maryville Pill Mill Draws 10year Prison Term, KNOXVILLE NEWS SENTINEL (Feb. 22, 2017),
https://www.knoxnews.com/story/news/crime/2017/02/22/doctor
-maryville-pill-mill-draws-10-year-prison-term/98268716/
[https://perma.cc/437L-KJ5V].
39 Prescribing Policies: States Confront Opioid Overdose
Epidemic, NAT’L CONF. ST. LEGISLATURES: STATE ACTION (Apr.
5, 2018), http://www.ncsl.org/research/health/prescribingpolicies-states-confront-opioid-overdose-epidemic.aspx
[https://perma.cc/VR62-LA4U].
40 Chris Elkins, The Opioid Epidemic: What Caused the Heroin
Epidemic?, DRUGREHAB.COM, https://www.drugrehab.com/
opioid-epidemic-causes/ [https://perma.cc/ZX2U-NZ7J]. The
Prescription Safety Act of 2016 is Tennessee’s version legislation that revised or made permanent existing regulation
of controlled substances and enacted several other provisions.
Tennessee Prescription Safety Act of 2016, 2016 Tenn. Pub.
37
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legislative initiatives, states have considered, proposed,
and/or adopted opioid-related legislation in a number of
other categories, including opioid taxes, pain clinic
licensure, training and education plans, and pill “takeback” programs.41
At the federal level, one hears numerous claims
that actions are being taken to “combat the opioid
crisis[,]”42 including President Trump’s plan to use the
death penalty as an option for drug dealers in fatal opioid
overdose cases.43 Not all have been deemed to be a
success. For example, an earlier piece of federal
legislation, the Ensuring Patient Access and Effective
Drug Enforcement Act of 2016, has been subjected to
scathing criticism, with even its title described as
“misleading.”44 According to a report resulting from a
joint investigation by The Washington Post and “60
Minutes,” an ex-DEA lawyer working for a
pharmaceutical company drafted an early version of the
Acts 1002 (codified at TENN. CODE ANN. §§ 53-10-301 to -312
(2016)).
41 Kate Blackman & Amber Widgery, Summer Progress in
Opioid Misuse Prevention Legislation, NAT’L CONF. ST.
LEGISLATURES:
NCSL
BLOG
(Aug.
31,
2017),
http://www.ncsl.org/blog/2017/08/31/summer-progress-inopioid-misuse-prevention-legislation.aspx [https://perma.cc/P
NT2-ZBM4].
42 See, e.g., Combatting the Opioid Crisis, HOUSE COMM. ON
ENERGY & COM.: ISSUE IN FOCUS, https://energycommerce.
house.gov/opioids/ [https://perma.cc/V9DA-VNW9].
43
Louise Radnofsky, Trump’s Opioid Battle Plan Includes
Seeking More Death-Penalty Prosecutions, WALL ST. J. (Mar.
18, 2018), https://www.wsj.com/articles/trumps-opioid-battleplan-includes-seeking-more-death-penalty-prosecutions1521414347 [https://perma.cc/D2JW-N3R6].
44 Scott Higham & Lenny Bernstein, New Drug Law Makes It
‘Harder for Us to Do Our Jobs,’ Former DEA Officials Say,
WASH. POST (Dec. 15, 2017), https://www.washington
post.com/graphics/2017/investigations/dea-law/?utm_term=.6c
c2264b1f35 [https://perma.cc/X 8YA-XEXH].
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law.45 The final version dramatically curtailed the DEA’s
enforcement powers: the agency now must demonstrate
that a company’s actions represent “a substantial
likelihood of an immediate threat” before it can halt drug
shipments, whereas previously it needed only to show
that they posed an “imminent danger” to the
community.46 The law also allows companies to submit
“corrective action plans” before they can be sanctioned by
the DEA,47 which one former DEA investigator called a
“get out of jail free card[.]”48
More recently, the new two-year budget deal
passed in early 2018 promised funding for the epidemic,
the details of which were not specified.49 Additionally, a
bipartisan group of senators introduced a follow-up bill to
2016’s Comprehensive Addiction and Recovery Act,
commonly referred to as CARA 2.0.50 A version of the bill
was introduced in the House of Representatives by
Tennessee Representative Marsha Blackburn.51 If
passed, CARA 2.0 would, among other things, commit
more funding to the fight against the opioid crisis,
restrict access to opioid painkillers, improve access for
medication-assisted treatment, and increase civil and
criminal penalties for opioid manufacturers if they fail to
report suspicious orders or fail to prevent diversion.52
The impact of Eric’s articles and its aftermath can
be seen far beyond the nation’s courtrooms and
Id.
Ensuring Patient Access and Effective Drug Enforcement
Act of 2016, Pub. L. No. 114-145, § 2(a)(1), 130 Stat. 354 (2016)
(codified as amended at 21 U.S.C. § 823 (2017)).
47 Ensuring Patient Access and Effective Drug Enforcement
Act of 2016, Pub. L. No. 114-145, § 2(a)(2), 130 Stat. 354
(codified as amended at 21 U.S.C. § 824 (2016)).
48 See Higham & Bernstein, supra note 44.
49 See, e.g., Bipartisan Budget Act of 2018, H.R. 1892, 115th
Cong. § 50723 (2018).
50 CARA 2.0 Act of 2018, S. 2456, 115th Cong. (2018).
51 CARA 2.0 Act of 2018, H.R. 5311, 115th Cong. (2018).
52 Id.
45
46
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legislatures, with some good results and some not as
positive. Eric discussed some of these results at the
symposium. For example, while he was relieved that
many of the opioid “pill mills” in West Virginia had been
shut down or had voluntarily closed their doors, he
suspected that a number of them had simply changed the
signs on their doors and morphed into “treatment
centers” that use medication to treat the opioid addicts
that they helped to create.
Medication-assisted
treatment
for
opioid
addiction is still very controversial.53 The main criticism
of using medication in this context is that it is just
replacing one drug - whether an opioid painkiller or
heroin - with another, such as methadone,
buprenorphine, and naltrexone.54 Research clearly
demonstrates, however, that medication improves
outcomes for patients with opioid use disorders.55
Along with the success of these treatments,
several tag-along legal issues have arisen which are
worthy of monitoring. One involves claims by the
Attorneys General of 35 states and the District of
Columbia that British pharmaceutical manufacturer
Indivior Inc. and U.S. company MonoSol Rx “product
hopped” in order to delay less expensive generic versions
See, e.g., Sameer Hassamal et al., Overcoming Barriers to
Initiating Medication-Assisted Treatment for Heroin Use
Disorder in a General Medical Hospital: A Case Report and
Narrative Literature Review, J. PSYCHOL. PRAC. 221 (2017).
54 Medication and Counseling Treatment, SUBSTANCE ABUSE &
MENTAL HEALTH ADMIN. (APR. 8, 2018), https://www.
samhsa.gov/medication-assisted-treatment/treatment
[https://perma.cc/5VC4-LULF]. Buprenorphine (Subutex) and
Buprenorphine-naloxone (Suboxone) were approved by the
U.S. FDA in 2002 to treat opiate dependence. Naloxone is the
drug used to revive overdose victims.
55 Mollie Durkin, Primary Care Takes on Opioid Addiction,
ACP INTERNIST: OPIOIDS (Oct. 2017), https://acpinternist.org/
archives/2017/10/primary-care-takes-on-opioid-addiction.htm
[https: //perma.cc/L49U-BM2H].
53
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of Suboxone, Indivior’s opioid addiction treatment drug.56
The defendants in that case are accused of conspiring to
create a sublingual film version of its Suboxone drug
shortly before its license expired in order to extend its
patent; of incrementally increasing the price of its tablets
and engaging in potentially misleading marketing to
encourage patients and doctors to switch to the new film
version; and of then announcing its intent to remove the
tablets from the market entirely.57
Another pharmaceutical manufacturer in the
ever-growing opioid treatment market has drawn fire for
its marketing practices. Alkermes, a Massachusetts
company, makes a monthly injectable treatment
medication called Vivitrol that blocks the effects of
opioids and reduces cravings, and the company has taken
its aggressive marketing pitch directly to drug court
judges, prosecutors, and other officials in the criminal
justice system who appear receptive to the “nonaddictive”
qualities of its product.58 According to medical
professionals, this approach is misleading and
contributes to the “existing stigma on the use of opioid
[methadone or buprenorphine] therapy in the treatment
of opioid addiction, despite a large and robust evidence
base showing [its] effectiveness . . . for opioid addiction.”59
In addition to the potentially predatory practices
of the companies and individuals seeking to exploit the
market for opioid addiction treatment, there are other
See Wisconsin v. Indivior Inc., Civ. No. 16-5073, 2017 WL
3967911 (E.D. Pa. Sept. 8, 2017).
57 Id.
58 See, e.g., Press Release, U.S. Senator Kamala Harris,
Senator Harris Launches Investigation into Pharmaceutical
Manufacturer Alkermes Regarding Opioid Addiction
Treatment Manipulation (Nov. 6, 2017), https://www.
harris.senate.gov/news/press-releases/senator-harrislaunches-investigation-into-pharmaceutical-manufactureralkermes-regarding-opioid-addiction-treatment-manipulation
[https://perma.cc/G5C7-YFKP].
59 Id.
56
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obvious downsides to the successful closure of many of
the unethical pill mills that blighted our rural
communities. Some of the poor souls who are no longer
able to access opioid prescriptions have turned to heroin
or to the very deadly synthetic opioid, fentanyl. According
to the CDC, “illicitly manufactured fentanyl is now a
major cause of opioid overdose deaths in multiple
states.”60 One law enforcement officer compared it to a
community weapon of mass destruction: “[i]t’s
manufactured death.”61
Hopefully, no one will be discouraged from
seeking to combat the opioid crisis in all of its forms,
whether the drug has been produced legally or illegally.
We should look to Eric’s efforts, and those of our
colleagues whose legal work supported him, for courage
and inspiration. The unsealed data that Eric and Pat et
al. secured in West Virginia are still among the only such
data that are publicly-available. The industry, with
support from the U.S. Department of Justice and the U.S.
DEA, is still demanding that its data be protected on the
grounds that disclosure could violate privacy rights,
breach trade secrets, interfere with law enforcement
investigations, and encourage criminal activity.62 This is
Maggie Fox, Synthetic Fentanyl Deaths Rise in Americans
Opioid Epidemic, NBC NEWS: HEALTH (Oct. 27, 2017),
https://www.nbcnews.com/storyline/americas-heroin-epidemic/
synthetic-fentanyl-deaths-rise-americans-opioid-epidemicn814956 [https://perma.cc/S42J-CTEH].
61 Nicole Lewis et al., Fentanyl Linked to Thousands of Urban
Overdose Deaths, WASH. POST: NAT’L (Aug. 17. 2017),
https://www.washingtonpost.com/graphics/2017/national/fent
anyl-overdoses/?utm_term=.d64447b619c9 [https://perma.cc/
ZRV4-N57W].
62 Letter from David A. Sierleja, First Assistant U.S. Attorney,
N. Dist. of Ohio, to Paul T. Ferrell, Jr., Partner, Green,
Ketchum, Farrell, Bailey & Tweel LLP (Feb. 26, 2018),
https://images.law.com/contrib/content/uploads/documents/39
8/11419/Critical-Mass-opioid-DOJ-letter.pdf [https://perma.cc/
EQ9L-FBGV].
60
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despite the Justice Department’s request to participate
in the settlement talks in the large MDL pending in the
Northern District of Ohio.63
This reluctance is understandable. The publiclyavailable raw numbers in Tennessee are sobering. In
Knox County alone, there were 294 suspected drug
overdose deaths in 2017 and 84 so far in 2018. Those are
not just numbers: those are our children, mothers,
fathers, siblings, and friends, and each leaves behind
grieving loved ones, all of whom deserve the best of our
combined professional efforts. As painful as the truth
may be, lawyers and journalists should be working to
uncover it, individually and as partners. Eric and his
legal support may be a tough, if not an impossible, act to
follow, but it is one to which I hope that we all will aspire.

United States’ Motion to Participate in Settlement
Discussions and as Friend of the Court, In re National
Prescription Opiate Litigation, MDL No. 1:17-MD-2804 (N.D.
Ohio April 2, 2018). This apparent cognitive dissonance
appears to be an issue amongst the manufacturing community,
too. OxyContin manufacturer Purdue Pharma recently
announced that it would stop promoting opioids to physicians,
see OxyContin Maker Purdue Pharma Stops Promoting
Opioids, Cuts Sales Staff, WASH. POST: HEALTH SCIENCE (Feb.
10, 2018), https://www.washingtonpost.com/national/healthscience/oxycontin-maker-purdue-pharma-to-stop-promotingthe-drug-to-doctors/2018/02/10/c59be118-0ea7-11e8-95a5c396801049ef_story.html
[https://perma.cc/9FR5-4WSP],
while at the same time “funneling $4.7 million to organizations
and physicians from 2012 through last year” that promoted the
use of opioid painkillers. Associated Press, Opioid Makers Gave
$10 Million to Drug Advocacy Groups Amid Epidemic, NBC
NEWS: NEWS (Feb. 18, 2018), https://www.nbcnews.com/storyline/
americas-heroin-epidemic/opioid-makers-gave-10m-advocacygroups-amid-epidemic-n849211 [https://perma.cc/LW39-63UK].
63
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